Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	G protein-coupled opioid receptor activity	NPBWR1 NPBWR2 OPRD1 OPRM1	1.05e-07	7	150	4	GO:0004985
GeneOntologyMolecularFunction	ATP-dependent activity	MYO1G ATP13A4 ERCC3 ERCC6 MCM8 ERCC6L MYO10 MCM2 DNAH14 DNAH12 ATP11B RECQL5 DNAH17 ATP11A DDX4 AQR AFG1L	3.83e-06	614	150	17	GO:0140657
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	ATP13A4 PKDREJ RYR1 RYR2 OPRM1 CHRNA10 CNGA3 MCOLN2	1.89e-05	151	150	8	GO:0015085
GeneOntologyMolecularFunction	helicase activity	ERCC3 ERCC6 MCM8 ERCC6L MCM2 RECQL5 DDX4 AQR	2.62e-05	158	150	8	GO:0004386
GeneOntologyMolecularFunction	ATP hydrolysis activity	ATP13A4 ERCC3 ERCC6 MCM8 ERCC6L MCM2 DNAH12 ATP11B RECQL5 ATP11A DDX4 AQR AFG1L	2.94e-05	441	150	13	GO:0016887
GeneOntologyMolecularFunction	calcium channel activity	PKDREJ RYR1 RYR2 OPRM1 CHRNA10 CNGA3 MCOLN2	5.46e-05	129	150	7	GO:0005262
GeneOntologyMolecularFunction	DNA helicase activity	ERCC3 ERCC6 MCM8 MCM2 RECQL5	1.03e-04	62	150	5	GO:0003678
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	RYR1 RYR2 CNGA3 MCOLN2	1.06e-04	33	150	4	GO:0005217
GeneOntologyMolecularFunction	neuropeptide binding	NPBWR1 NPBWR2 OPRD1 OPRM1	1.67e-04	37	150	4	GO:0042923
GeneOntologyMolecularFunction	malate dehydrogenase (decarboxylating) (NADP+) activity	ME1 ME3	1.67e-04	3	150	2	GO:0004473
GeneOntologyMolecularFunction	3'-5' DNA helicase activity	ERCC3 MCM2 RECQL5	2.17e-04	16	150	3	GO:0043138
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO1G MYO10 DNAH14 DNAH12 DNAH17 MYO16	2.68e-04	118	150	6	GO:0003774
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	RYR1 RYR2 MCOLN2	3.12e-04	18	150	3	GO:0015278
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH14 DNAH12 DNAH17	3.12e-04	18	150	3	GO:0008569
GeneOntologyMolecularFunction	malic enzyme activity	ME1 ME3	3.33e-04	4	150	2	GO:0004470
GeneOntologyMolecularFunction	oxaloacetate decarboxylase activity	ME1 ME3	3.33e-04	4	150	2	GO:0008948
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR2	3.33e-04	4	150	2	GO:0005219
GeneOntologyMolecularFunction	integrin binding	ITGA6 ITGAE GFAP NISCH TLN1 TLN2 CD151	3.62e-04	175	150	7	GO:0005178
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	ERCC3 ERCC6 MCM8 ERCC6L MCM2 RECQL5	3.98e-04	127	150	6	GO:0008094
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	VIM SPTAN1 GFAP EHHADH TLN1 TLN2	4.51e-04	130	150	6	GO:0005200
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	RYR1 RYR2 SCNN1G CHRNA10 CNGA3 MCOLN2	6.68e-04	140	150	6	GO:0099094
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ATP13A4 ERCC3 ERCC6 MCM8 ERCC6L MCM2 DNAH12 ATP11B RECQL5 IRGC ATP11A DDX4 AQR AGAP2 AFG1L	7.50e-04	775	150	15	GO:0017111
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR1 RYR2	8.24e-04	6	150	2	GO:0048763
GeneOntologyMolecularFunction	phosphatidylethanolamine flippase activity	ATP11B ATP11A	1.15e-03	7	150	2	GO:0090555
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	MARS2 ERCC3 RPP21 ERCC6 MCM8 ERCC6L GATB MCM2 KARS1 RECQL5 PIWIL3 DDX4 AQR	1.18e-03	645	150	13	GO:0140640
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH14 DNAH12 DNAH17	1.19e-03	28	150	3	GO:0051959
GeneOntologyMolecularFunction	malate dehydrogenase activity	ME1 ME3	1.52e-03	8	150	2	GO:0016615
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	RYR1 RYR2 MCOLN2	1.60e-03	31	150	3	GO:0099604
GeneOntologyMolecularFunction	pyrophosphatase activity	ATP13A4 ERCC3 ERCC6 MCM8 ERCC6L MCM2 DNAH12 ATP11B RECQL5 IRGC ATP11A DDX4 AQR AGAP2 AFG1L	1.65e-03	839	150	15	GO:0016462
GeneOntologyMolecularFunction	actin filament binding	MYO1G MYO10 SPTAN1 TLN1 TLN2 IQGAP3 MYO16	1.67e-03	227	150	7	GO:0051015
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ATP13A4 ERCC3 ERCC6 MCM8 ERCC6L MCM2 DNAH12 ATP11B RECQL5 IRGC ATP11A DDX4 AQR AGAP2 AFG1L	1.67e-03	840	150	15	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ATP13A4 ERCC3 ERCC6 MCM8 ERCC6L MCM2 DNAH12 ATP11B RECQL5 IRGC ATP11A DDX4 AQR AGAP2 AFG1L	1.67e-03	840	150	15	GO:0016818
GeneOntologyMolecularFunction	calmodulin binding	MYO1G MYO10 SPTAN1 RYR1 RYR2 TJP1 IQGAP3	1.80e-03	230	150	7	GO:0005516
GeneOntologyMolecularFunction	phosphatidylserine floppase activity	ATP11B ATP11A	1.95e-03	9	150	2	GO:0090556
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH14 DNAH12 DNAH17	2.68e-03	37	150	3	GO:0045505
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	ATP13A4 PKDREJ SLC25A37 RYR1 RYR2 OPRM1 SCNN1G CHRNA10 CNGA3 MCOLN2	2.75e-03	465	150	10	GO:0046873
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	ATP13A4 PKDREJ SLC25A37 RYR1 RYR2 NDUFV3 OPRM1 SLC15A1 SCNN1G CHRNA10 CNGA3 MCOLN2	2.79e-03	627	150	12	GO:0022890
GeneOntologyMolecularFunction	iron ion transmembrane transporter activity	SLC25A37 MCOLN2	2.95e-03	11	150	2	GO:0005381
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	RYR1 RYR2 SCNN1G CHRNA10 CNGA3 MCOLN2	3.42e-03	193	150	6	GO:0015276
GeneOntologyBiologicalProcess	G protein-coupled opioid receptor signaling pathway	NPBWR1 NPBWR2 OPRD1 OPRM1	1.87e-06	13	151	4	GO:0038003
Domain	P-loop_NTPase	MYO1G ERCC3 ERCC6 MCM8 ERCC6L MYO10 MCM2 SLFN5 DNAH14 DNAH12 TJP1 HS6ST1 RECQL5 IRGC DDX4 MYO16 AQR AGAP2 AFG1L	5.06e-05	848	150	19	IPR027417
Domain	-	TLN1 TLN2	6.41e-05	2	150	2	1.20.1420.10
Domain	Neuropept_B/W_rcpt	NPBWR1 NPBWR2	6.41e-05	2	150	2	IPR009150
Domain	VBS	TLN1 TLN2	6.41e-05	2	150	2	PF08913
Domain	Vinculin-bd_dom	TLN1 TLN2	6.41e-05	2	150	2	IPR015009
Domain	Talin_cent	TLN1 TLN2	6.41e-05	2	150	2	IPR015224
Domain	Sec15	EXOC6 EXOC6B	6.41e-05	2	150	2	PF04091
Domain	Talin_middle	TLN1 TLN2	6.41e-05	2	150	2	PF09141
Domain	EXOC6/Sec15	EXOC6 EXOC6B	6.41e-05	2	150	2	IPR007225
Domain	Malic_OxRdtase	ME1 ME3	1.91e-04	3	150	2	IPR001891
Domain	Malic_NAD-bd	ME1 ME3	1.91e-04	3	150	2	IPR012302
Domain	Malic_N_dom	ME1 ME3	1.91e-04	3	150	2	IPR012301
Domain	MALIC_ENZYMES	ME1 ME3	1.91e-04	3	150	2	PS00331
Domain	Malic_M	ME1 ME3	1.91e-04	3	150	2	PF03949
Domain	Malic_M	ME1 ME3	1.91e-04	3	150	2	SM00919
Domain	Ryanodine_rcpt	RYR1 RYR2	1.91e-04	3	150	2	IPR003032
Domain	malic	ME1 ME3	1.91e-04	3	150	2	PF00390
Domain	-	ME1 ME3	1.91e-04	3	150	2	3.40.50.10380
Domain	malic	ME1 ME3	1.91e-04	3	150	2	SM01274
Domain	Malic_enzyme_CS	ME1 ME3	1.91e-04	3	150	2	IPR015884
Domain	Talin-1	TLN1 TLN2	1.91e-04	3	150	2	IPR015710
Domain	Ryanrecept_TM4-6	RYR1 RYR2	1.91e-04	3	150	2	IPR009460
Domain	RyR	RYR1 RYR2	1.91e-04	3	150	2	PF02026
Domain	RR_TM4-6	RYR1 RYR2	1.91e-04	3	150	2	PF06459
Domain	Ryan_recept	RYR1 RYR2	1.91e-04	3	150	2	IPR013333
Domain	ILWEQ_dom	TLN1 TLN2	3.80e-04	4	150	2	IPR002558
Domain	Opioid_rcpt	OPRD1 OPRM1	3.80e-04	4	150	2	IPR001418
Domain	ILWEQ	TLN1 TLN2	3.80e-04	4	150	2	SM00307
Domain	FERM_f0	TLN1 TLN2	3.80e-04	4	150	2	PF16511
Domain	ILWEQ	TLN1 TLN2	3.80e-04	4	150	2	PD011820
Domain	DUF1394	CYRIB CYRIA	3.80e-04	4	150	2	IPR009828
Domain	-	TLN1 TLN2	3.80e-04	4	150	2	1.20.1410.10
Domain	I_LWEQ	TLN1 TLN2	3.80e-04	4	150	2	PF01608
Domain	DUF1394	CYRIB CYRIA	3.80e-04	4	150	2	PF07159
Domain	I_LWEQ	TLN1 TLN2	3.80e-04	4	150	2	PS50945
Domain	FERM_f0	TLN1 TLN2	3.80e-04	4	150	2	IPR032425
Domain	IQ	LRRIQ3 MYO10 UBE3C IQGAP3 MYO16	4.90e-04	81	150	5	SM00015
Domain	IQ_motif_EF-hand-BS	LRRIQ3 MYO10 UBE3C IQGAP3 MYO16	7.94e-04	90	150	5	IPR000048
Domain	IQ	LRRIQ3 MYO10 UBE3C IQGAP3 MYO16	9.21e-04	93	150	5	PS50096
Domain	RIH_assoc-dom	RYR1 RYR2	9.41e-04	6	150	2	IPR013662
Domain	Ins145_P3_rec	RYR1 RYR2	9.41e-04	6	150	2	PF08709
Domain	RIH_assoc	RYR1 RYR2	9.41e-04	6	150	2	PF08454
Domain	RIH_dom	RYR1 RYR2	9.41e-04	6	150	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2	9.41e-04	6	150	2	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR2	9.41e-04	6	150	2	IPR015925
Domain	-	RYR1 RYR2	9.41e-04	6	150	2	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR2	9.41e-04	6	150	2	PF01365
Domain	-	ERCC3 ERCC6 MCM8 ERCC6L MCM2 SLFN5 DNAH14 DNAH12 TJP1 RECQL5 IRGC DDX4 AQR AGAP2 AFG1L	9.98e-04	746	150	15	3.40.50.300
Domain	Vinculin/catenin	TLN1 TLN2	1.31e-03	7	150	2	IPR006077
Domain	Filament_head	VIM GFAP	1.31e-03	7	150	2	PF04732
Domain	Intermed_filament_DNA-bd	VIM GFAP	1.31e-03	7	150	2	IPR006821
Domain	TPR-contain_dom	RAPSN ERCC6L TMTC3 SH3TC1 P3H1 PRKDC	1.34e-03	150	150	6	IPR013026
Domain	Helicase_C	ERCC3 ERCC6 ERCC6L RECQL5 DDX4	1.72e-03	107	150	5	PF00271
Domain	HELICc	ERCC3 ERCC6 ERCC6L RECQL5 DDX4	1.72e-03	107	150	5	SM00490
Domain	MCM_OB	MCM8 MCM2	1.74e-03	8	150	2	PF17207
Domain	MCM_OB	MCM8 MCM2	1.74e-03	8	150	2	IPR033762
Domain	MCM_2	MCM8 MCM2	1.74e-03	8	150	2	PS50051
Domain	MCM_1	MCM8 MCM2	1.74e-03	8	150	2	PS00847
Domain	Helicase_C	ERCC3 ERCC6 ERCC6L RECQL5 DDX4	1.79e-03	108	150	5	IPR001650
Domain	HELICASE_CTER	ERCC3 ERCC6 ERCC6L RECQL5 DDX4	1.87e-03	109	150	5	PS51194
Domain	HELICASE_ATP_BIND_1	ERCC3 ERCC6 ERCC6L RECQL5 DDX4	1.87e-03	109	150	5	PS51192
Domain	DEXDc	ERCC3 ERCC6 ERCC6L RECQL5 DDX4	1.87e-03	109	150	5	SM00487
Domain	Helicase_ATP-bd	ERCC3 ERCC6 ERCC6L RECQL5 DDX4	1.95e-03	110	150	5	IPR014001
Domain	-	ATP13A4 ATP11B ATP11A	2.12e-03	32	150	3	3.40.1110.10
Domain	-	ATP13A4 ATP11B ATP11A	2.12e-03	32	150	3	2.70.150.10
Domain	TPR_REGION	RAPSN ERCC6L TMTC3 SH3TC1 P3H1 PRKDC	2.18e-03	165	150	6	PS50293
Domain	TPR	RAPSN ERCC6L TMTC3 SH3TC1 P3H1 PRKDC	2.18e-03	165	150	6	PS50005
Domain	MCM	MCM8 MCM2	2.22e-03	9	150	2	SM00350
Domain	MCM_dom	MCM8 MCM2	2.22e-03	9	150	2	IPR001208
Domain	MCM	MCM8 MCM2	2.22e-03	9	150	2	IPR031327
Domain	MCM	MCM8 MCM2	2.22e-03	9	150	2	PF00493
Domain	EF-hand_8	CAPN1 RYR1 RYR2	2.53e-03	34	150	3	PF13833
Domain	ATPase_P-typ_cyto_domN	ATP13A4 ATP11B ATP11A	2.75e-03	35	150	3	IPR023299
Domain	MIR	RYR1 RYR2	2.76e-03	10	150	2	PF02815
Domain	MIR_motif	RYR1 RYR2	2.76e-03	10	150	2	IPR016093
Domain	MIR	RYR1 RYR2	2.76e-03	10	150	2	PS50919
Domain	MIR	RYR1 RYR2	2.76e-03	10	150	2	SM00472
Domain	ATPase_P-typ_P_site	ATP13A4 ATP11B ATP11A	2.99e-03	36	150	3	IPR018303
Domain	P_typ_ATPase	ATP13A4 ATP11B ATP11A	2.99e-03	36	150	3	IPR001757
Domain	ATPASE_E1_E2	ATP13A4 ATP11B ATP11A	2.99e-03	36	150	3	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP13A4 ATP11B ATP11A	3.23e-03	37	150	3	IPR008250
Domain	E1-E2_ATPase	ATP13A4 ATP11B ATP11A	3.23e-03	37	150	3	PF00122
Domain	PKD_channel	PKDREJ MCOLN2	3.36e-03	11	150	2	PF08016
Domain	PKD1_2_channel	PKDREJ MCOLN2	3.36e-03	11	150	2	IPR013122
Domain	Myosin_head_motor_dom	MYO1G MYO10 MYO16	3.49e-03	38	150	3	IPR001609
Domain	MYOSIN_MOTOR	MYO1G MYO10 MYO16	3.49e-03	38	150	3	PS51456
Domain	Myosin_head	MYO1G MYO10 MYO16	3.49e-03	38	150	3	PF00063
Domain	MYSc	MYO1G MYO10 MYO16	3.49e-03	38	150	3	SM00242
Domain	NA-bd_OB-fold	MCM8 NAB1 MCM2 KARS1	4.49e-03	83	150	4	IPR012340
Domain	Dynein_heavy_chain_D4_dom	DNAH14 DNAH12	5.47e-03	14	150	2	IPR024317
Domain	P_typ_ATPase_c	ATP11B ATP11A	5.47e-03	14	150	2	IPR032630
Domain	P-type_ATPase_N	ATP11B ATP11A	5.47e-03	14	150	2	IPR032631
Domain	P-type_ATPase_IV	ATP11B ATP11A	5.47e-03	14	150	2	IPR006539
Domain	IRS	TLN1 TLN2	5.47e-03	14	150	2	PF02174
Domain	IRS_PTB	TLN1 TLN2	5.47e-03	14	150	2	IPR002404
Domain	AAA_8	DNAH14 DNAH12	5.47e-03	14	150	2	PF12780
Domain	PhoLip_ATPase_C	ATP11B ATP11A	5.47e-03	14	150	2	PF16212
Domain	PhoLip_ATPase_N	ATP11B ATP11A	5.47e-03	14	150	2	PF16209
Domain	Homeobox_metazoa	NKX2-3 TLX2 MSX1 MSX2	5.99e-03	90	150	4	IPR020479
Domain	FERM_M	MYO10 TLN1 TLN2	5.99e-03	46	150	3	PF00373
Pubmed	Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons.	RTN1 RYR1 RYR2	8.51e-08	3	154	3	23454728
Pubmed	GFAPδ expression in glia of the developmental and adolescent mouse brain.	VIM MCM2 GFAP	3.39e-07	4	154	3	23285135
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	EXOC6 ERCC6L DNAJC16 UFL1 RTN1 DIPK2A STT3B NDUFV3 KARS1 TMTC3 P3H1 NISCH TLN1 UGGT2 PRKDC IQGAP3 XPOT	1.06e-06	942	154	17	31073040
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MARS2 SPTAN1 GBE1 MCM2 UFL1 STK11IP PDIA3 STT3B TMTC3 TJP1 P3H1 CSNK2A2 UGGT2 ATP11A PRKDC UBE3C MMAB AQR XPOT RBM17	1.29e-06	1297	154	20	33545068
Pubmed	Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.	CAPN1 RYR1 RYR2	2.94e-06	7	154	3	20962236
Pubmed	Comparative phenotypic analysis of the two major splice isoforms of phosphatidylinositol phosphate kinase type Iγ in vivo.	ITGA6 TLN1 TLN2	7.01e-06	9	154	3	22976293
Pubmed	Msx1 and Msx2 are expressed in sub-populations of vascular smooth muscle cells.	GFAP MSX1 MSX2	7.01e-06	9	154	3	18627106
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	WDR36 SPTAN1 CAPN1 KARS1 SBF1 TJP1 CSNK2A2 TLN1 MCM3AP PRKDC PHIP AQR XPOT	7.45e-06	653	154	13	22586326
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYO10 ANKRD9 STK11IP AHDC1 RYR1 ACOX3 MSX2 SBF1 SH3TC1 NISCH TLN1 MCM3AP PDZD8 TLN2 PRKDC UBE3C IQGAP3	8.84e-06	1105	154	17	35748872
Pubmed	Generation of functional multipotent adult stem cells from GPR125+ germline progenitors.	VIM ITGA6 GFAP DDX4	9.26e-06	30	154	4	17882221
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYO10 DNAJC16 ADCY6 EPM2AIP1 NISCH TLN1 MCM3AP TRAK2 UBE3C AQR	1.48e-05	407	154	10	12693553
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MARS2 VIM WDR36 SPTAN1 MCM2 UFL1 PDIA3 STT3B KARS1 CSNK2A2 TLN1 TLN2 PRKDC UBE3C IQGAP3 PHIP AQR MCOLN2 XPOT	1.90e-05	1425	154	19	30948266
Pubmed	CD151 restricts the α6 integrin diffusion mode.	ITGA6 CD151	1.95e-05	2	154	2	22328509
Pubmed	Dissociation of the opioid receptor mechanisms that control mechanical and heat pain.	OPRD1 OPRM1	1.95e-05	2	154	2	19524516
Pubmed	Insertional mutation of the mouse Msx1 homeobox gene by an nlacZ reporter gene.	MSX1 MSX2	1.95e-05	2	154	2	9256350
Pubmed	Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice.	ITGAE PRKDC	1.95e-05	2	154	2	11086102
Pubmed	Calpain-dependent alpha-fodrin cleavage at the sarcolemma in muscle diseases.	SPTAN1 CAPN1	1.95e-05	2	154	2	15948206
Pubmed	Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents.	OPRD1 OPRM1	1.95e-05	2	154	2	31815916
Pubmed	Msx1 and Msx2 gene expression is downregulated in the cadmium-induced omphalocele in the chick model.	MSX1 MSX2	1.95e-05	2	154	2	20620318
Pubmed	Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin.	VIM GFAP	1.95e-05	2	154	2	10225952
Pubmed	Attenuation of reactive gliosis does not affect infarct volume in neonatal hypoxic-ischemic brain injury in mice.	VIM GFAP	1.95e-05	2	154	2	20442854
Pubmed	Vimentin Phosphorylation Is Required for Normal Cell Division of Immature Astrocytes.	VIM GFAP	1.95e-05	2	154	2	31480524
Pubmed	Ventral abdominal wall dysmorphogenesis of Msx1/Msx2 double-mutant mice.	MSX1 MSX2	1.95e-05	2	154	2	15803476
Pubmed	Involvement of delta and mu opioid receptors in the acute and sensitized locomotor action of cocaine in mice.	OPRD1 OPRM1	1.95e-05	2	154	2	23965295
Pubmed	Association Between Genetic Polymorphisms and Pain Sensitivity in Patients with Hip Osteoarthritis.	OPRD1 OPRM1	1.95e-05	2	154	2	29055075
Pubmed	The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors.	OPRD1 OPRM1	1.95e-05	2	154	2	11076532
Pubmed	Increased cell proliferation and neurogenesis in the hippocampal dentate gyrus of old GFAP(-/-)Vim(-/-) mice.	VIM GFAP	1.95e-05	2	154	2	15662841
Pubmed	Under stress, the absence of intermediate filaments from Müller cells in the retina has structural and functional consequences.	VIM GFAP	1.95e-05	2	154	2	15226376
Pubmed	Retinal functional alterations in mice lacking intermediate filament proteins glial fibrillary acidic protein and vimentin.	VIM GFAP	1.95e-05	2	154	2	26251181
Pubmed	Ectoderm-mesenchyme and mesenchyme-mesenchyme interactions regulate Msx-1 expression and cellular differentiation in the murine limb bud.	MSX1 MSX2	1.95e-05	2	154	2	7537232
Pubmed	CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.	ITGA6 CD151	1.95e-05	2	154	2	18451146
Pubmed	Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors.	OPRD1 OPRM1	1.95e-05	2	154	2	23836900
Pubmed	Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.	RYR1 RYR2	1.95e-05	2	154	2	17259277
Pubmed	Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression.	VIM GFAP	1.95e-05	2	154	2	11487638
Pubmed	Comparison of MSX-1 and MSX-2 suggests a molecular basis for functional redundancy.	MSX1 MSX2	1.95e-05	2	154	2	8861098
Pubmed	Regulated expression of homeobox genes Msx-1 and Msx-2 in mouse mammary gland development suggests a role in hormone action and epithelial-stromal interactions.	MSX1 MSX2	1.95e-05	2	154	2	8660900
Pubmed	Reanalysis of ATP11B, a type IV P-type ATPase.	ATP11B ATP11A	1.95e-05	2	154	2	11790799
Pubmed	Ryanodine receptor oligomeric interaction: identification of a putative binding region.	RYR1 RYR2	1.95e-05	2	154	2	14722100
Pubmed	Structural and functional interactions within ryanodine receptor.	RYR1 RYR2	1.95e-05	2	154	2	26009179
Pubmed	Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species.	ME1 ME3	1.95e-05	2	154	2	33619771
Pubmed	Functional roles of the tetramer organization of malic enzyme.	ME1 ME3	1.95e-05	2	154	2	19416979
Pubmed	Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.	RYR1 RYR2	1.95e-05	2	154	2	32899693
Pubmed	Vimentin and GFAP responses in astrocytes after contusion trauma to the murine brain.	VIM GFAP	1.95e-05	2	154	2	20479526
Pubmed	Contrasting effects of mu opioid receptor and delta opioid receptor deletion upon the behavioral and neurochemical effects of cocaine.	OPRD1 OPRM1	1.95e-05	2	154	2	15262338
Pubmed	Increased abundance of opioid receptor heteromers after chronic morphine administration.	OPRD1 OPRM1	1.95e-05	2	154	2	20647592
Pubmed	Normal and pathological expression of GFAP promoter elements in transgenic mice.	VIM GFAP	1.95e-05	2	154	2	7890332
Pubmed	Epithelial-mesenchymal interactions are required for msx 1 and msx 2 gene expression in the developing murine molar tooth.	MSX1 MSX2	1.95e-05	2	154	2	8101167
Pubmed	Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity.	OPRD1 OPRM1	1.95e-05	2	154	2	8930374
Pubmed	Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice.	VIM GFAP	1.95e-05	2	154	2	23038755
Pubmed	Msx homeobox gene family and craniofacial development.	MSX1 MSX2	1.95e-05	2	154	2	14728799
Pubmed	Disrupted glial fibrillary acidic protein network in astrocytes from vimentin knockout mice.	VIM GFAP	1.95e-05	2	154	2	8666670
Pubmed	Expression and distribution of CD151 as a partner of alpha6 integrin in male germ cells.	ITGA6 CD151	1.95e-05	2	154	2	32152440
Pubmed	Increased expression of glial fibrillary acidic protein fragments and mu-calpain activation within the hippocampus of prion-infected mice.	CAPN1 GFAP	1.95e-05	2	154	2	16417481
Pubmed	STAT4 isoforms differentially regulate Th1 cytokine production and the severity of inflammatory bowel disease.	STAT4 PRKDC	1.95e-05	2	154	2	18802110
Pubmed	Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin.	VIM GFAP	1.95e-05	2	154	2	17525210
Pubmed	Potentiation of dopamine D1-like receptor signaling by concomitant activation of δ- and μ-opioid receptors in mouse medial prefrontal cortex.	OPRD1 OPRM1	1.95e-05	2	154	2	23073238
Pubmed	Reactive glial cells: increased stiffness correlates with increased intermediate filament expression.	VIM GFAP	1.95e-05	2	154	2	20974670
Pubmed	Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses.	OPRD1 OPRM1	1.95e-05	2	154	2	10835636
Pubmed	Msh homeobox 1 (Msx1)- and Msx2-overexpressing bone marrow-derived mesenchymal stem cells resemble blastema cells and enhance regeneration in mice.	MSX1 MSX2	1.95e-05	2	154	2	28461333
Pubmed	Differential response to morphine of the oligomeric state of μ-opioid in the presence of δ-opioid receptors.	OPRD1 OPRM1	1.95e-05	2	154	2	21361347
Pubmed	μ- and δ-opioid-related processes in the accumbens core and shell differentially mediate the influence of reward-guided and stimulus-guided decisions on choice.	OPRD1 OPRM1	1.95e-05	2	154	2	22302826
Pubmed	Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis.	ITGA6 CD151	1.95e-05	2	154	2	11809818
Pubmed	Partial monosomy 9p (9p22.2-->pter) and partial trisomy 18q (18q21.32-->qter) in a female infant with anorectal malformations.	PIGN FREM1	1.95e-05	2	154	2	22876578
Pubmed	delta-, but not mu-, opioid receptor stabilizes K(+) homeostasis by reducing Ca(2+) influx in the cortex during acute hypoxia.	OPRD1 OPRM1	1.95e-05	2	154	2	17373650
Pubmed	[Induction phenomena during vertebrate limb development and homeo box gene expression].	MSX1 MSX2	1.95e-05	2	154	2	8099267
Pubmed	Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice.	OPRD1 OPRM1	1.95e-05	2	154	2	14622224
Pubmed	Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes.	VIM GFAP	1.95e-05	2	154	2	12861073
Pubmed	Generation of an Msx2-GFP conditional null allele.	MSX1 MSX2	1.95e-05	2	154	2	18442049
Pubmed	Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion.	RYR1 RYR2	1.95e-05	2	154	2	15033925
Pubmed	Mu and delta opioid receptor knockout mice show increased colonic sensitivity.	OPRD1 OPRM1	1.95e-05	2	154	2	27748566
Pubmed	Intermediate filaments regulate astrocyte motility.	VIM GFAP	1.95e-05	2	154	2	11701765
Pubmed	Site-directed mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility.	SPTAN1 CAPN1	1.95e-05	2	154	2	8993318
Pubmed	Expression of delta- and mu-opioid receptors in the ventricular and subventricular zones of the developing human neocortex.	OPRD1 OPRM1	1.95e-05	2	154	2	18455254
Pubmed	Loss of homeoprotein Msx1 and Msx2 leading to athletic and kinematic impairment related to the increasing neural excitability of neurons in aberrant neocortex in mice.	MSX1 MSX2	1.95e-05	2	154	2	31221479
Pubmed	Position-dependent expression of two related homeobox genes in developing vertebrate limbs.	MSX1 MSX2	1.95e-05	2	154	2	1677742
Pubmed	Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons.	OPRD1 OPRM1	1.95e-05	2	154	2	19357247
Pubmed	Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions.	OPRD1 OPRM1	1.95e-05	2	154	2	15657030
Pubmed	Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons.	OPRD1 OPRM1	1.95e-05	2	154	2	20615975
Pubmed	Disruption of Msx-1 and Msx-2 reveals roles for these genes in craniofacial, eye, and axial development.	MSX1 MSX2	1.95e-05	2	154	2	9142497
Pubmed	Distribution of delta and mu opioid receptor mRNA in rodent dorsal root ganglia neurons.	OPRD1 OPRM1	1.95e-05	2	154	2	35674691
Pubmed	MSX-1 gene expression and regulation in embryonic palatal tissue.	MSX1 MSX2	1.95e-05	2	154	2	9870533
Pubmed	Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.	TLN1 TLN2	1.95e-05	2	154	2	26822056
Pubmed	Extracellular rigidity sensing by talin isoform-specific mechanical linkages.	TLN1 TLN2	1.95e-05	2	154	2	26523364
Pubmed	Acute in utero morphine exposure slows G2/M phase transition in radial glial and basal progenitor cells in the dorsal telencephalon of the E15.5 embryonic mouse.	OPRD1 OPRM1	1.95e-05	2	154	2	18783375
Pubmed	Differential effect of membrane cholesterol removal on mu- and delta-opioid receptors: a parallel comparison of acute and chronic signaling to adenylyl cyclase.	OPRD1 OPRM1	1.95e-05	2	154	2	19520863
Pubmed	Expression patterns of the homeobox gene, Hox-8, in the mouse embryo suggest a role in specifying tooth initiation and shape.	MSX1 MSX2	1.95e-05	2	154	2	1358591
Pubmed	A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks.	OPRD1 OPRM1	1.95e-05	2	154	2	24623156
Pubmed	Altered taurine release following hypotonic stress in astrocytes from mice deficient for GFAP and vimentin.	VIM GFAP	1.95e-05	2	154	2	9795147
Pubmed	Calpain drives pyroptotic vimentin cleavage, intermediate filament loss, and cell rupture that mediates immunostimulation.	VIM CAPN1	1.95e-05	2	154	2	30796192
Pubmed	The intracellular trafficking of opioid receptors directed by carboxyl tail and a di-leucine motif in Neuro2A cells.	OPRD1 OPRM1	1.95e-05	2	154	2	12851402
Pubmed	Delta opioid receptor expression correlates to skin ageing and melanin expression in Asian women.	OPRD1 OPRM1	1.95e-05	2	154	2	38922774
Pubmed	Cloning and evolutionary analysis of msh-like homeobox genes from mouse, zebrafish and ascidian.	MSX1 MSX2	1.95e-05	2	154	2	1673109
Pubmed	Characterization of the mu and delta opioid receptors in the brain of the C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption.	OPRD1 OPRM1	1.95e-05	2	154	2	9194936
Pubmed	Abnormal reactivity of muller cells after retinal detachment in mice deficient in GFAP and vimentin.	VIM GFAP	1.95e-05	2	154	2	18469190
Pubmed	Differential impact of MSX1 and MSX2 homeogenes on mouse maxillofacial skeleton.	MSX1 MSX2	1.95e-05	2	154	2	18769023
Pubmed	Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings.	RUBCNL CCNA1	1.95e-05	2	154	2	19843677
Pubmed	Lack of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is accompanied by increased CK2α' levels.	CSNK2A2 PRKDC	1.95e-05	2	154	2	21750982
Pubmed	Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.	OPRD1 OPRM1	1.95e-05	2	154	2	22106286
Pubmed	Anti-analgesic effect of the mu/delta opioid receptor heteromer revealed by ligand-biased antagonism.	OPRD1 OPRM1	1.95e-05	2	154	2	23554887
Pubmed	In vitro and in vivo characterization of the bifunctional μ- and δ- opioid receptors ligand MCRT on mouse gastrointestinal motility.	OPRD1 OPRM1	1.95e-05	2	154	2	30738575
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2	1.06e-04	3	108	2	287
GeneFamily	Dyneins, axonemal	DNAH14 DNAH12 DNAH17	1.33e-04	17	108	3	536
GeneFamily	Opioid receptors	OPRD1 OPRM1	2.10e-04	4	108	2	245
GeneFamily	Intermediate filaments Type III	VIM GFAP	3.49e-04	5	108	2	610
GeneFamily	NKL subclass homeoboxes and pseudogenes	NKX2-3 TLX2 MSX1 MSX2	6.91e-04	67	108	4	519
GeneFamily	WD repeat domain containing\|ERCC excision repair associated	ERCC3 ERCC6	7.28e-04	7	108	2	1268
GeneFamily	MCM family	MCM8 MCM2	1.24e-03	9	108	2	1085
GeneFamily	Exocyst complex	EXOC6 EXOC6B	1.24e-03	9	108	2	1055
GeneFamily	Neuropeptide receptors	NPBWR1 NPBWR2	1.54e-03	10	108	2	854
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO10 TLN1 TLN2	3.31e-03	50	108	3	1293
GeneFamily	ATPase phospholipid transporting	ATP11B ATP11A	3.53e-03	15	108	2	1210
GeneFamily	WD repeat domain containing\|DDB1 and CUL4 associated factors	PHIP DCAF12	5.08e-03	18	108	2	498
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA6 ITGAE	5.08e-03	18	108	2	1160
GeneFamily	Glycosyl transferases group 1 domain containing\|Phosphatidylinositol glycan anchor biosynthesis	PIGN PIGM	6.89e-03	21	108	2	680
Coexpression	RIGGI_EWING_SARCOMA_PROGENITOR_UP	MYO10 RUBCNL FREM1 KMO STAT4 MSX1 RCOR1 ATP11B CYP2R1 SH3TC1 COL21A1 HS6ST1 SCNN1G ENPEP	2.80e-07	437	152	14	M15981
Coexpression	PEREZ_TP53_TARGETS	MYO10 ACO1 RIPOR3 AHDC1 ADCY6 DIPK2A MSX1 MSX2 CYRIA SH3TC1 EHHADH COL21A1 HS6ST1 CCNA1 FAM83G TSPYL5 ALDH4A1 TRAK2 MMP12 CNGA3 MCOLN2	6.34e-06	1201	152	21	M4391
Coexpression	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP	MYO1G MYO10 SLC25A37 STAT4 CYRIA USP12 MCOLN2 RBM17	1.98e-05	196	152	8	M8710
Coexpression	GSE27786_BCELL_VS_CD8_TCELL_UP	VIM EXOC6 HTR4 ERCC6L BHLHA9 ZBTB7A SH3TC1 HS6ST1	2.29e-05	200	152	8	M4801
ToppCell	droplet-Lung-nan-21m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRRIQ3 DNAJC16 ITGAE RTN1 KMO RYR1 IQGAP3	2.43e-06	173	154	7	2eb6e9fc3a3654f6f86fbd112e80a18814afd103
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATP13A4 GPC3 SCNN1G CNTN3 PLCL1 MMP12 PLXNB1	2.93e-06	178	154	7	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|368C / Donor, Lineage, Cell class and subclass (all cells)	ATP13A4 ERCC6 MCM8 MCM2 STK11IP ALDH4A1 AFG1L	3.04e-06	179	154	7	ec69e1dd897414033ba5b007aa82655a79adca6c
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 RIPOR3 SLC25A37 FREM1 TLN2 TRAK2 DCAF12	3.52e-06	183	154	7	1db466cf757813322db1cdcc0bf1d91c062fd9de
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	ATP13A4 ERCC6 MCM8 MCM2 STK11IP STAT4 ALDH4A1	3.92e-06	186	154	7	5cadab3271fce9ab6da3d7ba9827b8a221cac166
ToppCell	Influenza_Severe-RBC\|World / Disease group and Cell class	ANKRD9 RIPOR3 SLC25A37 TLN2 TRAK2 IQGAP3 DCAF12	4.21e-06	188	154	7	f0438e6a77ee1f0456cb65926685266fff470983
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 RUBCNL TLR7 ME1 RTN1 RYR1 CYRIA	4.83e-06	192	154	7	86d792682ba51696f503c79625dd20f87bcf651f
ToppCell	Endothelial-A\|World / shred on cell class and cell subclass (v4)	VIM ITGA6 ARMCX4 PRX TJP1 CD151 TRIM37	4.83e-06	192	154	7	9919cdc0ce833894525dba429f251ea1b094fbd8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 RUBCNL TLR7 ME1 RTN1 RYR1 CYRIA	4.83e-06	192	154	7	d0ad6a205ad50a3c523fa68676996b289eabc5de
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 RIPOR3 SLC25A37 USP12 TLN2 TRAK2 DCAF12	5.00e-06	193	154	7	305e15ee467826ee08b2617c69f250ad39c11b19
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 RUBCNL TLR7 ME1 RTN1 RYR1 CYRIA	5.00e-06	193	154	7	f597fefc54327a1ad136e2f66b6e81cc5c761eb7
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 RIPOR3 SLC25A37 USP12 TLN2 TRAK2 DCAF12	5.00e-06	193	154	7	dd376664906caccc9c2065f8e7a364509e18a5cc
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO10 FREM1 RYR2 GPC3 COL21A1 MYO16 MCOLN2	6.11e-06	199	154	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	WDR36 GBE1 RYR2 GPC3 COL21A1 MYO16 MCOLN2	6.11e-06	199	154	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO10 FREM1 RYR2 GPC3 COL21A1 ENPEP MCOLN2	6.31e-06	200	154	7	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO10 FREM1 RYR2 GPC3 COL21A1 MYO16 MCOLN2	6.31e-06	200	154	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	droplet-Heart-nan-3m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGAE SLC25A37 KMO RYR1 AGAP2 DCAF12	9.38e-06	140	154	6	ab90f6f30d89761687f8836e3d327d143ce49ed4
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FREM1 OR2A12 HS6ST1 SCNN1G PLXNB1	1.44e-05	151	154	6	f4f7156b2c0cfc78fd1841e07c9915d97ced561f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLFN5 ADCY6 STAT4 CCNA1 CNTN3 PLCL1	1.93e-05	159	154	6	5ca96db4281abb5f646150ccf36adc66ab201c78
ToppCell	facs-Marrow-T-cells-24m-Hematologic-MPP_Fraction_B\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPSN AHDC1 SLC25A37 SH3TC1 ALDH4A1 MCOLN2	2.00e-05	160	154	6	b3f7ef7e682b48a83ca425f5c439336e96168300
ToppCell	356C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYO10 PCDHGA3 TLR7 RYR2 GPC3 MCOLN2	2.00e-05	160	154	6	0293b244c063a62819690bf22bbc2681f8d15252
ToppCell	356C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MYO10 PCDHGA3 TLR7 RYR2 GPC3 MCOLN2	2.00e-05	160	154	6	3eaae86fa08f7651021316f8e5811bf48055591e
ToppCell	droplet-Heart-nan-24m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G RUBCNL ITGAE SLC25A37 KMO RYR1	2.07e-05	161	154	6	7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRP1B FREM1 HS6ST1 ALDH4A1 PLCL1 MCOLN2	2.46e-05	166	154	6	a42268a02a89fc97272e45c4cbe21acf04b7428c
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYO1G NAB1 TLR7 RYR1 CYRIA TLN1	2.64e-05	168	154	6	4b5be7c6662eceddf90a65015f12908278d1664e
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYO1G NAB1 TLR7 RYR1 CYRIA TLN1	2.64e-05	168	154	6	689c41f6e9f65381570991cc311cba49a57ec955
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGAE RTN1 KMO RYR1 SH3TC1 EXOC6B	2.73e-05	169	154	6	46f0f0de9a0894c454f93032e7a7a800f47c8276
ToppCell	droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G RUBCNL RAPGEF4 TLR7 RYR1 CYRIA	2.91e-05	171	154	6	e852d0e8589eecf4a2e5fea039b52a67c5d58dbd
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VIM ATP13A4 MYO10 GFAP MSX1 MSX2	3.01e-05	172	154	6	55fba5ce0ead1114e1a76f67ad68432c6bac90e5
ToppCell	facs-Aorta-Heart-3m-Myeloid\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G ITGAE SLC25A37 CYRIB KMO DCAF12	3.11e-05	173	154	6	513b4d31bcfb269556c6b4cc389865fb12e52c4f
ToppCell	droplet-Marrow-nan-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACO1 SLFN5 CYRIA SH3TC1 UGGT2 PLCL1	3.21e-05	174	154	6	55cc8300489d11322724159ec7d0e1d32a702e91
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPGEF4 GBE1 ME1 ENPEP SERPIND1 XPOT	3.31e-05	175	154	6	5c38d4b6c03473d841e6203a7efaa6dcb2d59386
ToppCell	droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LRRIQ3 ERCC6L DNAJC16 RTN1 RYR1 IQGAP3	3.31e-05	175	154	6	73f25bd54309aed1480ddc44bdab518b17e71f92
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-NK_T_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO1G MARCHF10 PKDREJ STAT4 OPRM1 DDX4	3.53e-05	177	154	6	89e9ac601bc80bd33141da84056189950e563a1e
ToppCell	10x5'-GI_large-bowel-Mast\|GI_large-bowel / Manually curated celltypes from each tissue	ANKRD9 FREM1 MSX2 GPC3 CCNA1 ALDH4A1	3.65e-05	178	154	6	d10ed2543c96e1a2373f847e0b82144771e26d07
ToppCell	10x5'-GI_large-bowel-Mast-Mast_cells\|GI_large-bowel / Manually curated celltypes from each tissue	ANKRD9 FREM1 MSX2 GPC3 CCNA1 ALDH4A1	3.65e-05	178	154	6	8fc5f735afa25ae43c2acb1c710ade6e9e093e3c
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 RIPOR3 SLC25A37 TLN2 TRAK2 DCAF12	3.76e-05	179	154	6	dfefa4b7ae0ee50cf67e0f1938c682f08a03ec53
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-hematologic-erythrocytic\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 RIPOR3 SLC25A37 TLN2 TRAK2 DCAF12	3.76e-05	179	154	6	64672528f73ac0921f9c7df72e14ecbfac4d5270
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-hematologic\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 RIPOR3 SLC25A37 TLN2 TRAK2 DCAF12	3.76e-05	179	154	6	fa0dd87111d399649cdea55f2e610ebc169e8a56
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FREM1 RYR2 GPC3 COL21A1 MYO16 MCOLN2	3.88e-05	180	154	6	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO10 FREM1 RYR2 GPC3 COL21A1 ENPEP	4.00e-05	181	154	6	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ANKRD9 RIPOR3 SLC25A37 USP12 TRAK2 DCAF12	4.13e-05	182	154	6	93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 RIPOR3 SLC25A37 TLN2 TRAK2 DCAF12	4.25e-05	183	154	6	b52d7683dc6652766e814ebe935c264ecd610c4b
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD9 RIPOR3 SLC25A37 TLN2 TRAK2 DCAF12	4.25e-05	183	154	6	1d77d8d8c8f78f43dd8864e76f294ee66d4942c2
ToppCell	Control-APC-like-Dendritic_cells\|Control / group, cell type (main and fine annotations)	RUBCNL RTN1 CYRIB CYRIA SH3TC1 MCOLN2	4.25e-05	183	154	6	8f9c8e2436f18ea7c265b08e4e149e19cb513a16
ToppCell	Control-APC-like\|Control / group, cell type (main and fine annotations)	RUBCNL RTN1 CYRIB CYRIA SH3TC1 MCOLN2	4.25e-05	183	154	6	c313ac72cc9fa1583456d452393f61f0a4ca33a8
ToppCell	10x5'v1-week_17-19-Hematopoietic-MK-MK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ITGA6 RIPOR3 ADCY6 RYR2 TLN1 SLC35D3	4.25e-05	183	154	6	9c66a40c355387f805dbdca4162dd05af5c1d8d4
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 LRP1B FREM1 RYR2 TLN2 MYO16	4.39e-05	184	154	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 LRP1B FREM1 RYR2 TLN2 MYO16	4.39e-05	184	154	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 LRP1B FREM1 RYR2 TLN2 MYO16	4.39e-05	184	154	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VIM ATP13A4 MYO10 GFAP MSX1 MSX2	4.39e-05	184	154	6	22c18964818fc9c8f18051f836d718937b0d8d12
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ITGA6 LRP1B MSX1 COL21A1 HS6ST1 TLN2	4.66e-05	186	154	6	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	droplet-Tongue-nan-24m-Myeloid-Langerhans_cell\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G VIM ITGAE RTN1 STAT4 MMP12	4.66e-05	186	154	6	3e16781b9646de971d953da2c49d4210a4c23fe3
ToppCell	LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKRD9 RIPOR3 SLC25A37 ATP11B TRAK2 DCAF12	4.66e-05	186	154	6	e5014443e9d6e25943308483e20d48b776ae5373
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	CCDC170 ADCY6 GPC3 HS6ST1 EXOC6B TLN2	4.66e-05	186	154	6	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	LPS_only-Hematopoietic_Meg-Ery-Erythroid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKRD9 RIPOR3 SLC25A37 ATP11B TRAK2 DCAF12	4.66e-05	186	154	6	affc246a1091e44dc85a5e237c778a7541d5a2b4
ToppCell	LPS_only-Hematopoietic_Meg-Ery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANKRD9 RIPOR3 SLC25A37 ATP11B TRAK2 DCAF12	4.66e-05	186	154	6	40d1e15402fdfb3b5ae850a2070cd4b68fda3159
ToppCell	droplet-Tongue-nan-24m-Myeloid\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G VIM ITGAE RTN1 STAT4 MMP12	4.66e-05	186	154	6	298ea4c7f61df65537dfef171ca81d4e976d89c5
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	CCDC170 ADCY6 GPC3 HS6ST1 EXOC6B TLN2	4.66e-05	186	154	6	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	severe_influenza-RBC\|World / disease group, cell group and cell class (v2)	ANKRD9 RIPOR3 SLC25A37 TLN2 TRAK2 DCAF12	4.80e-05	187	154	6	f846750575f318503d21ade30f5bfd2e1d4c84af
ToppCell	10x5'v1-week_17-19-Hematopoietic-MK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ITGA6 RIPOR3 ADCY6 RYR2 TLN1 SLC35D3	4.80e-05	187	154	6	34cad5ac8602fe88ca3d421257190c9a388d4cb0
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	MYO10 FREM1 RYR2 GPC3 COL21A1 MCOLN2	4.80e-05	187	154	6	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANKRD9 RIPOR3 SLC25A37 USP12 TRAK2 DCAF12	4.94e-05	188	154	6	f81099b5b3f1f85a28445bc663efcf73baccb2be
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANKRD9 RIPOR3 SLC25A37 USP12 TRAK2 DCAF12	4.94e-05	188	154	6	05b3ade422beeb3db73d350fe192c21bfcfef188
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO1G RUBCNL RTN1 KMO RYR1 MCOLN2	5.09e-05	189	154	6	31c8bc506ad69f2ed5676bd7e5319bad1075c8d8
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 FREM1 GPC3 COL21A1 CNTN3 ENPEP	5.09e-05	189	154	6	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RUBCNL ME1 RTN1 CYRIB RYR1 CYRIA	5.09e-05	189	154	6	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LRP1B RYR2 STAT4 COL21A1 ENPEP MYO16	5.24e-05	190	154	6	7986586b7c82e91c71102cc8c4d7a689ae63ab4d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 RUBCNL TLR7 ME1 RTN1 RYR1	5.24e-05	190	154	6	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	severe_COVID-19-RBC\|severe_COVID-19 / disease group, cell group and cell class (v2)	ANKRD9 RIPOR3 SLC25A37 TLN2 TRAK2 DCAF12	5.24e-05	190	154	6	3a5723c2daf58c1932edd70910db4b8b30f63f42
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 RUBCNL TLR7 ME1 RTN1 RYR1	5.40e-05	191	154	6	baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CCDC170 RUBCNL TLR7 RTN1 KMO RYR1	5.40e-05	191	154	6	09dfad8e1fcaaf94775134796b99e4e3fbb9bf40
ToppCell	10x5'v1-week_14-16-Hematopoietic-MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ITGA6 ADCY6 FREM1 RYR2 TLN1 SLC35D3	5.40e-05	191	154	6	7edc22e7e70697fb22690699efb352577162709b
ToppCell	facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WDR36 NAB1 ITGA6 MCM2 PDIA3 CYRIB	5.55e-05	192	154	6	ec1fd2fb6e71f87189d66261909a84e2be63cacb
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)\|Adult / Lineage, Cell type, age group and donor	CCDC170 RUBCNL ME1 RTN1 RYR1 CYRIA	5.72e-05	193	154	6	31c0978ba78c9516d498aec0798902e57555e557
ToppCell	Immune-interstitial_macrophage_(C1Q_positive)\|World / Lineage, Cell type, age group and donor	CCDC170 RUBCNL ME1 RTN1 RYR1 CYRIA	5.72e-05	193	154	6	64d598162a256ac6c9f8280c8a9133661dfbb10f
ToppCell	wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ANKRD9 RIPOR3 SLC25A37 USP12 TRAK2 DCAF12	5.72e-05	193	154	6	be75abfdf5301cf33df8ee9ed92504d44fdf19a6
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	MYO10 FREM1 RYR2 GPC3 COL21A1 CNTN3	5.72e-05	193	154	6	acad568621ed677031797b8c2e34dafea798d681
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RAPSN PDLIM4 GPC3 COL21A1 TLN2 CD151	5.72e-05	193	154	6	02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1
ToppCell	CF-Myeloid-Monocyte\|CF / Disease state, Lineage and Cell class	MYO1G VIM PDIA3 KMO CYRIA USP12	5.72e-05	193	154	6	3a83b2593a37a075f91354745e5a7a081ec406a8
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 FREM1 RYR2 GPC3 COL21A1 CNTN3	5.88e-05	194	154	6	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO10 ITGA6 SLFN5 ARMCX4 PRX TJP1	5.88e-05	194	154	6	1b382508453c5b08fb617f626b230adf3b6cff99
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LRRIQ3 MYO10 ACO1 MCM2 SBF1 TRIM37	5.88e-05	194	154	6	8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 FREM1 RYR2 GPC3 COL21A1 CNTN3	5.88e-05	194	154	6	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 RUBCNL ME1 RTN1 RYR1 CYRIA	5.88e-05	194	154	6	1dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CCDC170 RUBCNL TLR7 RTN1 KMO RYR1	6.05e-05	195	154	6	e8fb552f9ab77b656c27abc66af523b56cd9f9ad
ToppCell	10x5'v1-week_14-16-Hematopoietic-MK-early_MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDIA3 ADCY6 FREM1 TLN1 SLC35D3 PDZD8	6.05e-05	195	154	6	9b4f217325afb2efb9c65f298ac87649cb1e1af9
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	FREM1 RYR2 GPC3 COL21A1 ENPEP MCOLN2	6.05e-05	195	154	6	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 RUBCNL ME1 RTN1 RYR1 CYRIA	6.05e-05	195	154	6	42bfdff88da1d07828c0ad65d412fb1752f0cee4
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO10 ITGA6 SLFN5 ARMCX4 PRX TJP1	6.05e-05	195	154	6	cd011433b3b9bfb1adb13eca2f3f2a5db024cd94
ToppCell	facs-Heart-RA-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO10 ITGA6 SLFN5 SH3TC1 TJP1 TRIM37	6.05e-05	195	154	6	30c75761079fa1e1a3b84d23c88a222f459d5ce5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CCDC170 RUBCNL ME1 RTN1 RYR1 CYRIA	6.05e-05	195	154	6	34a9462f4e843f3065cc58c17ad71c1b5b836ae1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RUBCNL TLR7 ME1 RTN1 RYR1 CYRIA	6.23e-05	196	154	6	4370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO10 FREM1 RYR2 GPC3 COL21A1 MYO16	6.40e-05	197	154	6	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO10 LRP1B FREM1 GPC3 COL21A1 CNTN3	6.40e-05	197	154	6	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RAPSN PDLIM4 GPC3 COL21A1 TLN2 CD151	6.59e-05	198	154	6	55e583321f60c95898d93cd0d2615c6692db52ec
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	FREM1 RYR2 COL21A1 RECQL5 MYO16 MCOLN2	6.59e-05	198	154	6	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RAPSN PDLIM4 GPC3 COL21A1 TLN2 CD151	6.77e-05	199	154	6	e19b296d583f8bad3b66ee998a8153634d6fe09e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO10 FREM1 GPC3 COL21A1 MYO16 MCOLN2	6.77e-05	199	154	6	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Transverse-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	DNAJC16 GBE1 ME1 ME3 MSX2 CYP2R1	6.77e-05	199	154	6	fd75dccb37d96448edf72b7d042b06833d4ead24
Drug	Methadone	OPRD1 OPRM1 CHRNA10	1.21e-06	4	154	3	DB00333
Drug	dl-Bremazocine	NPBWR1 NPBWR2 OPRD1 OPRM1 DDX4	1.96e-06	31	154	5	CID000001223
Drug	Dantrolene	VIM CAPN1 GFAP RYR1 RYR2	8.17e-06	41	154	5	ctd:D003620
Drug	Tropine [120-29-6]; Down 200; 28.4uM; PC3; HT_HG-U133A	SPTAN1 SLC25A37 KMO ACOX3 RYR2 MSX2 SBF1 RECQL5 ALDH4A1	8.47e-06	198	154	9	5790_DN
Drug	cobyric acid	ITGA6 KARS1 MMAB	1.04e-05	7	154	3	CID006857443
Drug	CYM51010	OPRD1 OPRM1	4.55e-05	2	154	2	ctd:C583602
Drug	5-methylmethadone	OPRD1 OPRM1	4.55e-05	2	154	2	CID006452481
Drug	Dimethylthiambutene	OPRD1 OPRM1	4.55e-05	2	154	2	DB01444
Drug	3,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamidopropyl)-2(1H)-pyrazinone	OPRD1 OPRM1	4.55e-05	2	154	2	ctd:C507635
Drug	1,6-bis(N,N-dimethyl-2',6'-dimethyltyrosyl-1,2,3,4-tetrahydro-3-isoquinolineamido)hexane	OPRD1 OPRM1	4.55e-05	2	154	2	ctd:C507634
Drug	Oxymorphone	OPRD1 OPRM1	4.55e-05	2	154	2	DB01192
Drug	Hydrocodone	OPRD1 OPRM1	4.55e-05	2	154	2	DB00956
Drug	endomorphin 1	OPRD1 OPRM1	4.55e-05	2	154	2	ctd:C105293
Drug	P 7556	OPRD1 OPRM1	4.55e-05	2	154	2	CID000131855
Drug	P 7618	OPRD1 OPRM1	4.55e-05	2	154	2	CID000126194
Drug	methyl 2-(3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo(2,3-a)quinolizin-2-yl)-3-methoxyacrylate	OPRD1 OPRM1	4.55e-05	2	154	2	ctd:C587452
Drug	P 7548	OPRD1 OPRM1	4.55e-05	2	154	2	CID000127329
Drug	Diphenoxylate	OPRD1 OPRM1	4.55e-05	2	154	2	DB01081
Drug	N-cyclopropylmethyl-4-hydroxy-14-methoxymorphinan	OPRD1 OPRM1	4.55e-05	2	154	2	CID005486977
Drug	N-Cyclopropylmethyl-4,14-dimethoxymorphinan	OPRD1 OPRM1	4.55e-05	2	154	2	CID005486976
Drug	Liden	OPRD1 OPRM1	4.55e-05	2	154	2	CID000010072
Drug	Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; HL60; HT_HG-U133A	SPTAN1 SBF1 SH3TC1 TLN2 ATP11A PLCL1 CHRNA10 AGAP2	5.43e-05	194	154	8	2959_UP
Drug	levo-dromoran tartrate	NPBWR1 NPBWR2 ADCY6 OPRD1 OPRM1 DDX4	5.48e-05	98	154	6	CID000003918
Drug	Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A	VIM MYO10 AHDC1 CYRIB RANBP17 P3H1 ALDH4A1 ENPEP	6.05e-05	197	154	8	1508_DN
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A	DNAJC16 ME3 PDLIM4 SLC15A1 MCM3AP EXOC6B ATP11A AGAP2	6.27e-05	198	154	8	3842_UP
Drug	Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	GATB SLC25A37 CYRIB RANBP17 ZBTB7A TJP1 RECQL5 UGGT2	6.27e-05	198	154	8	6256_DN
Drug	Fusaric acid [536-69-6]; Down 200; 22.4uM; PC3; HT_HG-U133A	RAPSN KMO ZBTB7A GPC3 CYP2R1 RECQL5 EXOC6B TLN2	6.27e-05	198	154	8	3986_DN
Drug	Pheniramine maleate [132-20-7]; Up 200; 11.2uM; MCF7; HT_HG-U133A	PIGN DNAJC16 AHDC1 ATP11B SLC15A1 MCM3AP RECQL5 ATP11A	6.73e-05	200	154	8	1492_UP
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A	RYR2 RANBP17 SBF1 CYP2R1 SLC15A1 RECQL5 ALDH4A1 PLXNB1	6.73e-05	200	154	8	7456_UP
Drug	Ultracet	HTR4 OPRD1 OPRM1 CHRNA10 ENPEP	7.33e-05	64	154	5	CID000005523
Drug	glutamate	ACO1 GATB ME1 GFAP ADCY6 SLC25A37 KMO RYR1 RYR2 ME3 KARS1 SCNN1G ALDH4A1 CHRNA10 ENPEP TRIM37 AGAP2 MCOLN2	9.24e-05	962	154	18	CID000000611
Drug	AC1L1DSZ	ADCY6 OPRD1 OPRM1 TLX2	1.00e-04	36	154	4	CID000002494
Drug	Dale	ACO1 OPRD1 ZBTB7A ENPEP DDX4	1.21e-04	71	154	5	CID005486816
Drug	Ketazocina	OPRD1 OPRM1 DDX4	1.30e-04	15	154	3	CID000071426
Drug	Fedotozina	HTR4 OPRD1 OPRM1	1.30e-04	15	154	3	CID000060764
Drug	phenoxybenzamine	HTR4 ADCY6 OPRD1 OPRM1 CHRNA10 DDX4	1.33e-04	115	154	6	CID000004768
Drug	TRK 820	OPRD1 OPRM1	1.36e-04	3	154	2	ctd:C111212
Drug	Oxycodone	OPRD1 OPRM1	1.36e-04	3	154	2	DB00497
Drug	Hydromorphone	OPRD1 OPRM1	1.36e-04	3	154	2	DB00327
Drug	Codeine	OPRD1 OPRM1	1.36e-04	3	154	2	DB00318
Drug	Carfentanil	OPRD1 OPRM1	1.36e-04	3	154	2	DB01535
Drug	Morphine	OPRD1 OPRM1	1.36e-04	3	154	2	DB00295
Drug	Hydrocodone	OPRD1 OPRM1	1.36e-04	3	154	2	ctd:D006853
Drug	3-Methylfentanyl	OPRD1 OPRM1	1.36e-04	3	154	2	DB01571
Drug	Heroin	OPRD1 OPRM1	1.36e-04	3	154	2	DB01452
Drug	3-Methylthiofentanyl	OPRD1 OPRM1	1.36e-04	3	154	2	DB01439
Drug	morphine-7,8-oxide	OPRD1 OPRM1	1.36e-04	3	154	2	CID005491901
Drug	Levorphanol	OPRD1 OPRM1	1.36e-04	3	154	2	ctd:D007981
Drug	Levallorphan	OPRD1 OPRM1	1.36e-04	3	154	2	ctd:D007977
Drug	mitragynine pseudoindoxyl	OPRD1 OPRM1	1.36e-04	3	154	2	ctd:C121049
Drug	cis-diammineplatinum(II	RYR1 RYR2	1.36e-04	3	154	2	CID000159790
Drug	2-hydroxyheptanoic acid	RYR1 RYR2	1.36e-04	3	154	2	CID002750949
Drug	8N3-cADPR	RYR1 RYR2	1.36e-04	3	154	2	CID000127713
Drug	Buprenorphine	OPRD1 OPRM1	1.36e-04	3	154	2	DB00921
Drug	aminodantrolene	RYR1 RYR2	1.36e-04	3	154	2	CID009570289
Drug	Levorphanol	OPRD1 OPRM1	1.36e-04	3	154	2	DB00854
Drug	Remifentanil	OPRD1 OPRM1	1.36e-04	3	154	2	DB00899
Drug	Nalbuphine	OPRD1 OPRM1	1.36e-04	3	154	2	DB00844
Drug	Fentanyl	OPRD1 OPRM1	1.36e-04	3	154	2	DB00813
Drug	Cytochrophin-4	OPRD1 OPRM1	1.36e-04	3	154	2	CID000126809
Drug	Sufentanil	OPRD1 OPRM1	1.36e-04	3	154	2	DB00708
Drug	Enkephalin, Leucine	OPRD1 OPRM1	1.36e-04	3	154	2	ctd:D004743
Drug	Propoxyphene	OPRD1 OPRM1	1.36e-04	3	154	2	DB00647
Drug	Butorphanol	OPRD1 OPRM1	1.36e-04	3	154	2	DB00611
Drug	Butorphanol	OPRD1 OPRM1	1.36e-04	3	154	2	ctd:D002077
Drug	cyclorphan	OPRD1 OPRM1	1.36e-04	3	154	2	ctd:C084603
Drug	Alvimopan	OPRD1 OPRM1	1.36e-04	3	154	2	DB06274
Drug	2-hydroxycarbazole	RYR1 RYR2	1.36e-04	3	154	2	CID000093551
Drug	dextrallorphan	OPRD1 OPRM1	1.36e-04	3	154	2	ctd:C044130
Drug	14-phenylpropoxymetopon	OPRD1 OPRM1	1.36e-04	3	154	2	ctd:C478565
Drug	CID5362039	OPRD1 OPRM1	1.36e-04	3	154	2	CID005362039
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR1 RYR2	1.36e-04	3	154	2	CID005748312
Drug	AC1L4LFH	GFAP OPRD1 TLX2	1.59e-04	16	154	3	CID000187734
Drug	varanic acid	ACOX3 TMTC3 EHHADH	1.59e-04	16	154	3	CID003080578
Drug	Skl tripeptide	ME1 ACOX3 ME3 CSNK2A2	1.84e-04	42	154	4	CID000131223
Drug	fentanyl isothiocyanate	ADCY6 OPRD1 OPRM1	1.92e-04	17	154	3	CID000084008
Drug	Dalce	OPRD1 OPRM1 TLX2	1.92e-04	17	154	3	CID005486712
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; HL60; HT_HG-U133A	SPTAN1 RUBCNL PRX STAT4 SH3TC1 DNAH17 EXOC6B	2.00e-04	176	154	7	2926_UP
Drug	Aminosweet	STT3B OPRD1 OPRM1 ENPEP	2.02e-04	43	154	4	CID000002242
Drug	MR 2034	OPRD1 OPRM1 DDX4	2.30e-04	18	154	3	CID000123980
Drug	benzeneacetamide	ADCY6 OPRD1 OPRM1 DDX4	2.63e-04	46	154	4	CID000007680
Drug	Dynorphins	OPRD1 OPRM1	2.70e-04	4	154	2	ctd:D004399
Drug	AC1L5BQM	OPRD1 OPRM1	2.70e-04	4	154	2	CID000174892
Drug	Diprenorphine	OPRD1 OPRM1	2.70e-04	4	154	2	DB01548
Drug	4-amino-4-phosphonobutyric acid	STT3B ENPEP	2.70e-04	4	154	2	CID000098450
Drug	Dmt-NMe-Ala-Aba-Gly-NH2	OPRD1 OPRM1	2.70e-04	4	154	2	ctd:C569763
Drug	3B-b	OPRD1 OPRM1	2.70e-04	4	154	2	CID000533975
Drug	PCB74	RYR1 RYR2	2.70e-04	4	154	2	CID000036218
Drug	phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide	OPRD1 OPRM1	2.70e-04	4	154	2	ctd:C049352
Drug	tyrosyl-tetrahydroisoquinolinecarbonyl-psi(methylamino)phenylalanyl-phenylalanine	OPRD1 OPRM1	2.70e-04	4	154	2	ctd:C092721
Drug	Naltrexone	OPRD1 OPRM1	2.70e-04	4	154	2	DB00704
Drug	AC1OCQTX	OPRD1 OPRM1	2.70e-04	4	154	2	CID000824375
Drug	endomorphin 2	OPRD1 OPRM1	2.70e-04	4	154	2	ctd:C105294
Drug	148504-47-6	RYR1 RYR2	2.70e-04	4	154	2	CID006444275
Drug	SC 38249	RYR1 RYR2	2.70e-04	4	154	2	CID000134834
Drug	Methadyl Acetate	OPRD1 OPRM1	2.70e-04	4	154	2	ctd:D008692
Drug	deltorphin II, Ala(2)-	OPRD1 OPRM1	2.70e-04	4	154	2	ctd:C060209
Drug	AC1L1U7A	RYR1 RYR2	2.70e-04	4	154	2	CID000035682
Drug	7-hydroxymitragynine	OPRD1 OPRM1	2.70e-04	4	154	2	ctd:C482678
Drug	NSC292252	OPRD1 OPRM1 DDX4	2.72e-04	19	154	3	CID000431328
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2	7.68e-05	3	150	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2	7.68e-05	3	150	2	DOID:8545 (implicated_via_orthology)
Disease	Hypotension, Orthostatic	OPRD1 OPRM1	7.68e-05	3	150	2	C0020651
Disease	porphyria (implicated_via_orthology)	ACO1 GBE1	2.54e-04	5	150	2	DOID:13268 (implicated_via_orthology)
Disease	monocyte percentage of leukocytes	MYO1G RAPSN HTR4 NKX2-3 NSUN7 DNAH12 MCM3AP USP12 PRKDC MMAB MYO16 DCAF12	3.75e-04	731	150	12	EFO_0007989
Disease	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	RAPSN RYR1	3.80e-04	6	150	2	C1854678
Disease	asphyxia neonatorum (biomarker_via_orthology)	ERCC3 PDIA3	3.80e-04	6	150	2	DOID:11088 (biomarker_via_orthology)
Disease	Cockayne syndrome (implicated_via_orthology)	ERCC3 ERCC6	3.80e-04	6	150	2	DOID:2962 (implicated_via_orthology)
Disease	lymphocyte count	CCDC170 MYO1G EXOC6 RAPSN HTR4 PCDHGA3 NKX2-3 RIPOR3 CYRIB ME3 PDLIM4 ZBTB7A HS6ST1 TLN1 MCM3AP DNAH17 DCAF12 RBM17	4.76e-04	1464	150	18	EFO_0004587
Disease	mean corpuscular hemoglobin concentration	RAPSN ANKRD9 NAB1 NKX2-3 SLC25A37 CYRIB OPRD1 ME3 CYRIA ATP11B PRKDC UBE3C MMAB MYO16 DCAF12	5.30e-04	1105	150	15	EFO_0004528
Disease	neuroticism measurement, cognitive function measurement	HTR4 SDCCAG8 GATB GBE1 LRP1B STT3B ZBTB7A CCNA1 PLCL1 AFG1L	6.63e-04	566	150	10	EFO_0007660, EFO_0008354
Disease	adult onset asthma, type 2 diabetes mellitus	EXOC6 RAPSN	7.04e-04	8	150	2	EFO_1002011, MONDO_0005148
Disease	Pena-Shokeir syndrome type I	RAPSN GBE1	7.04e-04	8	150	2	C1276035
Disease	pulmonary hypertension (biomarker_via_orthology)	VIM PDIA3 RYR1 RYR2	7.52e-04	80	150	4	DOID:6432 (biomarker_via_orthology)
Disease	mean reticulocyte volume	RAPSN ANKRD9 CYRIB ME3 ZBTB7A CYRIA RCOR1 TMTC3 TLN2 MMAB TRIM37 MYO16	8.19e-04	799	150	12	EFO_0010701
Disease	beverage consumption measurement	SDCCAG8 GATB RYR2 PLCL1	8.63e-04	83	150	4	EFO_0010088
Disease	reticulocyte count	MYO1G ANKRD9 NAB1 SLC25A37 CYRIB RCOR1 ATP11B NISCH DNAH17 TLN2 ATP11A MMAB DCAF12 AFG1L	9.25e-04	1045	150	14	EFO_0007986
Disease	rheumatoid arthritis, Crohn's disease	RAPSN NKX2-3 STAT4	9.53e-04	38	150	3	EFO_0000384, EFO_0000685
Disease	Parkinson's disease (implicated_via_orthology)	ATP13A4 NPBWR1 NPBWR2 OPRD1 OPRM1	1.27e-03	157	150	5	DOID:14330 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease	PRX SBF1 MCM3AP	1.28e-03	42	150	3	cv:C0007959
Disease	virologic response measurement, response to abacavir	PIGN IYD OPRM1	1.28e-03	42	150	3	EFO_0006905, EFO_0006906
Disease	hereditary spastic paraplegia (implicated_via_orthology)	ATP13A4 CAPN1 RTN1	1.37e-03	43	150	3	DOID:2476 (implicated_via_orthology)
Disease	Weight Gain	VIM MYO10 ME1 MMP12	1.85e-03	102	150	4	C0043094
Disease	fatty acid measurement, fetal genotype effect measurement, breast milk measurement	RAPSN FAM135B	1.93e-03	13	150	2	EFO_0005110, EFO_0007959, EFO_0009092
Disease	Fulminant Hepatic Failure with Cerebral Edema	OPRM1 PRKDC	1.93e-03	13	150	2	C0751197
Disease	Hepatic Stupor	OPRM1 PRKDC	1.93e-03	13	150	2	C0751198
Disease	Sjogren's Syndrome	STAT4 PHIP	1.93e-03	13	150	2	C1527336
Disease	Hepatic Encephalopathy	OPRM1 PRKDC	1.93e-03	13	150	2	C0019151
Disease	Hepatic Coma	OPRM1 PRKDC	1.93e-03	13	150	2	C0019147
Disease	autoimmune hepatitis (is_implicated_in)	PDIA3 STAT4	1.93e-03	13	150	2	DOID:2048 (is_implicated_in)
Disease	Charcot-Marie-Tooth disease type 4	PRX SBF1	1.93e-03	13	150	2	cv:C4082197
Disease	Sicca Syndrome	STAT4 PHIP	1.93e-03	13	150	2	C0086981
Disease	mean platelet volume	RAPSN PCDHGA3 SDCCAG8 NAB1 ITGA6 SLC25A37 OPRD1 CYRIA RCOR1 ITPRIP CD151 MMAB PHIP	2.18e-03	1020	150	13	EFO_0004584
Disease	receptive language perception, parental genotype effect measurement	IYD SCNN1G	2.24e-03	14	150	2	EFO_0005686, EFO_0005939
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	RAPSN FAM135B	2.24e-03	14	150	2	EFO_0005110, EFO_0005939, EFO_0009092
Disease	lysophosphatidylcholine 15:0 measurement	PATL1 LRP1B	2.24e-03	14	150	2	EFO_0020941
Disease	granulocyte percentage of myeloid white cells	MYO1G RAPSN HTR4 NKX2-3 PRKDC DCAF12	2.55e-03	268	150	6	EFO_0007997
Disease	prostate specific antigen measurement	SLC25A37 GPC3 SERPINA13P PLCL1 PHIP	2.80e-03	188	150	5	EFO_0004624
Disease	reticulocyte measurement	ANKRD9 NAB1 SLC25A37 CYRIB RCOR1 ATP11B NISCH DNAH17 TLN2 ATP11A MMAB DCAF12 AFG1L	2.87e-03	1053	150	13	EFO_0010700
Disease	phosphatidylcholine 38:6 measurement	RAPSN CPO	2.94e-03	16	150	2	EFO_0010388
Disease	peanut allergy measurement	ITGA6 MMP12	2.94e-03	16	150	2	EFO_0007017
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	TLR7 TJP1	3.32e-03	17	150	2	DOID:8677 (biomarker_via_orthology)
Disease	Tachycardia	HTR4 RYR2	3.72e-03	18	150	2	C0039231
Disease	Tachyarrhythmia	HTR4 RYR2	3.72e-03	18	150	2	C0080203
Disease	Sjogren's syndrome (is_implicated_in)	VIM STAT4	3.72e-03	18	150	2	DOID:12894 (is_implicated_in)
Disease	mood instability measurement	RAPSN HTR4 LRP1B PLCL1	4.20e-03	128	150	4	EFO_0008475
Disease	RS-warfarin measurement	EXOC6 NPBWR1 LRP1B PHIP	4.20e-03	128	150	4	EFO_0803325
Disease	urate measurement, bone density	GBE1 RIPOR3 DNAH14 FREM1 RANBP17 CSNK2A2 UGGT2 PRKDC MYO16	4.52e-03	619	150	9	EFO_0003923, EFO_0004531
Disease	BRCAX breast cancer	CCDC170 DCAF12	4.59e-03	20	150	2	EFO_0009443
Disease	Craniosynostosis	FREM1 MSX2	4.59e-03	20	150	2	C0010278
Disease	polymyositis	NAB1 MMAB	4.59e-03	20	150	2	EFO_0003063
Disease	Dermatitis, Allergic Contact	TLR7 KMO CNTN3	4.86e-03	67	150	3	C0162820
Disease	COVID-19 (is_implicated_in)	TLR7 IFNL1	5.06e-03	21	150	2	DOID:0080600 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
FFNLNKLEDSRYGRL	ACO1	21	P21399
LKLFRDLFANYTSAL	CHRNA10	31	Q9GZZ6
ELVNQIYLEARKFSF	DDX4	376	Q9NQI0
ELNFLRCKRIFEYDF	ACOX3	76	O15254
FQSKQFRSAKLERLY	ADCY6	126	O43306
NFQLYRDAIRFLLCL	ATP13A4	391	Q4VNC1
DVALENFFRYFLRLS	FTHL17	46	Q9BXU8
KRILDYNEAFNALRR	BHLHA9	76	Q7RTU4
YLELSKNFDTIFLRN	AFG1L	361	Q8WV93
LRFIDAVYKLLRDQF	CEP44	71	Q9C0F1
LIDFFRFNAKYAVEL	ALDH4A1	166	P30038
LRNIYKAEENFEFLI	AGAP2	866	Q99490
NLNSIRFLAKAIDYE	GATB	281	O75879
LLRNFNLFRLESTYE	AQR	466	O60306
EYSDVLAKLAFLNRQ	AHDC1	611	Q5TGY3
RIRNYLSIFRKFDLD	CAPN1	616	P07384
DNSSIRKLLRNLDFY	CPO	131	Q8IVL8
KQRRFFKSNDLYELF	ERCC6	991	Q03468
LSLFENINYHFKRRA	ARMCX4	2226	Q5H9R4
KNFFVNYRRRFNIDE	RCOR1	421	Q9UKL0
LNEKYFSELRASLIN	RANBP17	1011	Q9H2T7
FNSAELLAKELYRVF	RUBCNL	336	Q9H714
FLLESYLNLARSNEK	RAPSN	81	Q13702
FVLQRSLYRKTLDSF	ITPRIP	506	Q8IWB1
SNQFEYDFLLQRITK	MMP12	446	P39900
RQRSLLEKELLFFAY	P3H1	366	Q32P28
LNILNAKFAFNLYRV	SERPIND1	126	P05546
YLSFRRDNNELLLFI	MCM2	821	P49736
LFSRYVDRQKLNLLE	PATL1	746	Q86TB9
SLRNEEVKNAFYKLF	OR8K5	291	Q8NH50
RFYEFSIRLEKALQS	CYRIA	91	Q9H0Q0
SQERRKILSLFYSLF	OR2A12	266	Q8NGT7
VLYAFLDENFKRCFR	OPRM1	336	P35372
FKNVIALAFDYNQRR	LRP1B	2221	Q9NZR2
DFANVNAFRLLNKYR	ME1	246	P48163
DFYLELRKQSQRLNS	MCM8	691	Q9UJA3
QIAEFFRDLLAKSLY	MYO16	731	Q9Y6X6
RILQKANLLSYFDAF	NAB1	16	Q13506
VKNQLRFLAELAYDL	GPC3	516	P51654
QIRKDALRALNFAYT	MCM3AP	876	O60318
SLLFYDIRAQKFLEE	DCAF12L2	371	Q5VW00
RALQYAFFAERKANK	EHHADH	266	Q08426
AFLEINRQLLFREYL	EID2B	86	Q96D98
FFKRKYQQLNLESIR	ITGAE	1151	P38570
ASAYFLFLRRDLQAQ	PLXNB1	226	O43157
YFLNATILFLFRELR	PDZD8	96	Q8NEN9
SQAIDKNLLRFDYDR	FREM1	151	Q5H8C1
DDFITRNKYLLAARL	DNAJC16	351	Q9Y2G8
AFANILLNDIASKYR	DNAH12	486	Q6ZR08
DLLNLLRESRFDFIY	MYO10	571	Q9HD67
DAFALARAQLLDYKV	ENPEP	661	Q07075
NKASDYLVDLIAFLR	EXOC6B	636	Q9Y2D4
NRKFSLFAERKYQTL	ITGA6	951	P23229
LNDRFASYIEKVRFL	GFAP	76	P14136
YAFLDDNFRKNFRSI	NPBWR2	316	P48146
NRLFDLLFEIRDQYN	EXOC6	411	Q8TAG9
FQRKTQYLFERTFNL	HS6ST1	296	O60243
QYLFERTFNLKFIRP	HS6ST1	301	O60243
KIQAFFRARKAQDDY	IQGAP3	826	Q86VI3
LKQVDFSRYDFFLLV	IRGC	126	Q6NXR0
KVLFLSRSYQRLADA	SBF1	236	O95248
VLYAFLDENFKRCFR	OPRD1	316	P41143
ALRSFDYEQFRDLKL	PCDHGA3	516	Q9Y5H0
ELILLFDQSRYRFVN	ADAM30	206	Q9UKF2
DDDLLRYKFLNNFDR	GBE1	571	Q04446
FLAKRNFQIDVYEAR	KMO	26	O15229
ERASLLYFILNDLNK	DNAH17	3656	Q9UFH2
SLLFYDIRAQRFLEE	DCAF12	361	Q5T6F0
LRNQLFNRARDFKAY	EPM2AIP1	161	Q7L775
LFRNAAVVYDFLSRL	CYP2R1	246	Q6VVX0
RLLDFLNVKNVYFAQ	DIPK2A	81	Q8NDZ4
RAETLYLAVNFLDRF	CCNA1	261	P78396
FNLFRLLTRDLKYVA	IFNL1	171	Q8IU54
QFALDYLFAKSSRFL	COL21A1	121	Q96P44
LYAFLNKSFRRAFLI	HTR4	311	Q13639
RKSSFAFYQAVRDLL	ANKRD9	31	Q96BM1
DFKQLYQILTDFDIR	CSNK2A2	121	P19784
SKEFEAILNRFRNYF	DNAH14	711	Q0VDD8
RDRQKFFSDVQYLRD	MARCHF10	6	Q8NA82
DFANANAFRLLNKYR	ME3	281	Q16798
KKFYEFSQRLEAALR	CYRIB	91	Q9NUQ9
SQYFSFREKIAALLR	CCDC170	321	Q8IYT3
FADNVFALKEYAIRL	ERCC3	561	P19447
TFRDNADLRKCFLYQ	FAM135B	1281	Q49AJ0
ATFKERRNLLRLYFI	CD151	81	P48509
NILFRRTFKLLDFEQ	PIWIL3	226	Q7Z3Z3
EKQRNRFFSIFYLAI	SLC15A1	156	P46059
KYNTLRLERAFSNQL	SCNN1G	626	P51170
EVQRVKFLNYLSRNF	RYR1	4546	P21817
SIEKRFAYSFLQQLI	RYR2	2916	Q92736
FELERRFKQQRYLSA	NKX2-3	161	Q8TAU0
SREAKLQFAYLENFK	CNTN3	111	Q9P232
KNSSFFRLEFYRLLQ	MCOLN2	206	Q8IZK6
FRYFSKQELRELFTI	ERCC6L	616	Q2NKX8
KFLNRLSDYLFTLAR	MMAB	211	Q96EY8
LYAFLDASFRRNLRQ	NPBWR1	306	P48145
QEFYELLNKRRSVRF	IYD	91	Q6PHW0
FRQKQYLSIAERAEF	MSX2	161	P35548
FYEVLKRENIRDFLS	FAM83G	46	A6ND36
YDRFSEARILFLLQL	PEX16	291	Q9Y5Y5
FYVNSTLKELRRLFL	RTN1	681	Q16799
SLEARQFFYLRAFLV	STK11IP	941	Q8N1F8
ANLDLFLRRFNEIQF	RAPGEF4	811	Q8WZA2
NILLKFLISRYQFSF	SLC35D3	26	Q5M8T2
NRFFRLDLLANEGYL	TRIM37	376	O94972
YLDLILNDFVRQKFI	KARS1	231	Q15046
FRQKQYLSIAERAEF	MSX1	191	P28360
SQLKFLRNDLAEYQR	SDCCAG8	241	Q86SQ7
LYDFQDRKFQTRVLS	NSUN7	131	Q8NE18
FLKAASNLRDNYRFA	PDIA3	171	P30101
EVYLVRKNLTFAAFN	PKDREJ	951	Q9NTG1
LNLKQRGYFFLDERL	PDLIM4	286	P50479
EFFKYFLTKRQLENR	SLC25A37	321	Q9NYZ2
KDREAFQRLNFLYQA	RPP21	6	Q9H633
IAFFIYKRRLNENTD	SLCO6A1	686	Q86UG4
LLDREKSLFFYQKAR	SH3TC1	1291	Q8TE82
NRLLKFSRLFEFFDR	CNGA3	276	Q16281
ERQRNLFLKAFTDFL	ATP11A	336	P98196
LRFISDFLAFLVLYN	ATP11B	336	Q9Y2G3
FRANLFYDVQFKELI	RECQL5	221	O94762
LRRQNYLSEKQFFAE	TRAK2	491	O60296
YNRFFTLDTDLQALR	PLCL1	131	Q15111
FLVLRQQFDDAKYRR	PHIP	1051	Q8WWQ0
SFREKALLFYTNALA	RIPOR3	851	Q96MK2
LLLRRKFFYSDQNVD	TLN1	191	Q9Y490
FLQYLRDRLTKQEFQ	STT3B	336	Q8TCJ2
LERVTFLIYNLFKNS	STAT4	301	Q14765
RRQKLEDSYRFQFFQ	SPTAN1	36	Q13813
RLNDSYRLQRFLADF	SPTAN1	356	Q13813
FYNLDKFRVLDLAEQ	RBM17	386	Q96I25
FFENFKYEDALRLLQ	PRX	71	Q9BXM0
LQEFLRQLLTFYKVA	NISCH	831	Q9Y2I1
FITRLRKENELFDNY	USP12	106	O75317
NDRFANYIDKVRFLE	VIM	111	P08670
QLNKLFYREEFVLAT	ZBED10P	61	Q96FA7
VSNIDFAFKLYRQLA	SERPINA13P	51	Q6UXR4
TKEENYIFRLSQFRK	MARS2	206	Q96GW9
FRQLYLDDIRRAFFL	PIGN	776	O95427
LAELRYLDFSNNRLD	TLR7	541	Q9NYK1
RSLTKYFLQDAFQLR	TLR7	736	Q9NYK1
LIFENLIDLKRRYNF	PRKDC	1976	P78527
RKQLSYFDRRSFENK	TJP1	1356	Q07157
DFRQRALAYFEQLKI	XPOT	16	O43592
ETLLLRRKFFYSDQN	TLN2	191	Q9Y4G6
SDLRDNLTAFQKYLI	UGGT2	281	Q9NYU1
LENEKNFERALKYFL	TMTC3	456	Q6ZXV5
DKSLRQFRYTFQACL	PIGM	201	Q9H3S5
LFCLDLYRSLEQFKA	UHRF1BP1	551	Q6BDS2
SAAALFDRKRLQYLE	SLFN5	171	Q08AF3
FRQNGYLEFDALSRL	UFL1	261	O94874
QRNLLRAKEYLEFFQ	ZBTB7A	151	O95365
LLVRQLLFFYKQNED	UBE3C	96	Q15386
FLRQKYLASAERAAL	TLX2	176	O43763
NAQADRAYLRLSRKF	TSPYL5	216	Q86VY4
RKRDFELAQAYLALF	WDR36	886	Q8NI36
FNYLEKARERKALFL	LRRIQ3	491	A6PVS8
RDFLFQDFKRLLYNS	MYO1G	536	B0I1T2
TYTFLDLNLELSKFR	NDUFV3	81	P56181